Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Shares Outstanding (2022 - 2025)

CervoMed (CRVO) has disclosed Shares Outstanding for 9 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 6.32% to $9.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.3 million through Dec 2025, up 6.32% year-over-year, with the annual reading at $9.3 million for FY2025, 6.32% up from the prior year.
  • Shares Outstanding hit $9.3 million in Q4 2025 for CervoMed, roughly flat from $9.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $50.0 million in Q2 2024 to a low of $518140.0 in Q2 2022.
  • Historically, Shares Outstanding has averaged $10.7 million across 4 years, with a median of $5.7 million in 2023.
  • Biggest five-year swings in Shares Outstanding: surged 9545.45% in 2024 and later tumbled 81.49% in 2025.
  • Year by year, Shares Outstanding stood at $3.3 million in 2022, then surged by 70.34% to $5.7 million in 2023, then soared by 53.36% to $8.7 million in 2024, then grew by 6.32% to $9.3 million in 2025.
  • Business Quant data shows Shares Outstanding for CRVO at $9.3 million in Q4 2025, $9.3 million in Q3 2025, and $9.3 million in Q2 2025.